Preclinical & Clinical Trials\ Quality assurance

CosmosID, Inc.

CosmosID is a leading provider of end-to-end microbiome analysis solutions.

CosmosID® provides end-to-end solutions unlocking the microbiome. A provider of CLIA-certified & GxP-compliant NGS, metabolomics and bioinformatics aolutions, CosmosID offers a range of validated and optimized workflows for early and late stage R&D.

CosmosID also offers independently validated, industry-leading pipelines for processing metagenomic data, yielding multi-kingdom, strain-level resolution with leading sensitivity and precision. Results can be accessed via CosmosID-HUB, a user-friendly and interactive software for comparative analysis of microbiome data, complete with dynamic charts, visualizations, and statistics.

Market area

Asia-Pacific · Europe · North America

Headquarter

Germantown, MD USA

External links

Request CosmosID, Inc.'s resources

CosmosID - Bacterial Isolate Characterization via Whole-Genome Sequencing

CosmosID - End-to-End Microbiome Analysis via Next Generation Sequencing

Fill the form below to contact CosmosID, Inc.

Recipient Company Name

Recipient Company Email

First Name(Required)

Last Name(Required)

Country(Required)

Your Job Title

Your Company(Required)

Work email address(Required)

Work phone number

Message

By submitting this form, you acknowledge that you have read and understand our Privacy Policy

I agree to the privacy policy

Personal Data Treatment(Required)

By submitting this form, you agree that the above personal data is provided to a third party company.

I agree to provide my data to third-party companies

Name

This field is for validation purposes and should be left unchanged.